| Bela D Desai, MD | |
|
77 Rand Rd, Des Plaines, IL 60016-1005 | |
| (847) 803-1344 | |
| (847) 803-3791 |
| Full Name | Bela D Desai |
|---|---|
| Gender | Female |
| Speciality | Geriatric Medicine |
| Experience | 32 Years |
| Location | 77 Rand Rd, Des Plaines, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063556991 | NPI | - | NPPES |
| 036100458 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0300X | Internal Medicine - Geriatric Medicine | 036100458 (Illinois) | Secondary |
| 207R00000X | Internal Medicine | 036100458 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Advocate Home Health Care Serv | Lombard, IL | Home health agency |
| Advocate Lutheran General Hospital | Park ridge, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advocate Health And Hospitals Corporation | 7810800935 | 2422 |
News Archive
Newly-created bioactive peptides promote wound healing through the growth of new blood vessels and epithelial tissue, such as skin. These wound-healing peptides, synthesized by researchers at the Tufts Center for Innovations in Wound Healing Research, increased angiogenesis in vitro by 200 percent.
A new treatment option for Canadians with schizophrenia, ABILIFY(TM) (aripiprazole), is now available in Canada. For those living with this lifelong disease who may be struggling with a treatment that doesn't work for them or with side effects that are difficult to tolerate, ABILIFY offers efficacy and good safety and tolerability with limited impact on weight, blood sugar and lipids - significant clinical benefits that may help patients stay on treatment longer.
Allergan plc and Merck, known as MSD outside the United States and Canada, today announced that they have entered into an agreement under which Allergan will acquire the exclusive worldwide rights to Merck's investigational small molecule oral calcitonin gene-related peptide (CGRP) receptor antagonists, which are being developed for the treatment and prevention of migraine, subject to expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR).
A study that used a Utah genealogic database and a statewide cancer registry to examine the relationship between Parkinson disease (PD) and cancer suggests an increased risk of prostate cancer and melanoma in patients with PD and their relatives, according to a report published Online First by Archives of Neurology, a JAMA Network publication.
Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders, which is being conducted in collaboration with Pfizer. As previously reported, the companies recently selected a candidate compound to advance into further clinical studies. Dosing of this candidate compound has now been initiated in a Phase I study in healthy volunteers.
› Verified 1 days ago
| Entity Name | Advocate Health And Hospitals Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700824455 PECOS PAC ID: 7810800935 Enrollment ID: O20031106000064 |
News Archive
Newly-created bioactive peptides promote wound healing through the growth of new blood vessels and epithelial tissue, such as skin. These wound-healing peptides, synthesized by researchers at the Tufts Center for Innovations in Wound Healing Research, increased angiogenesis in vitro by 200 percent.
A new treatment option for Canadians with schizophrenia, ABILIFY(TM) (aripiprazole), is now available in Canada. For those living with this lifelong disease who may be struggling with a treatment that doesn't work for them or with side effects that are difficult to tolerate, ABILIFY offers efficacy and good safety and tolerability with limited impact on weight, blood sugar and lipids - significant clinical benefits that may help patients stay on treatment longer.
Allergan plc and Merck, known as MSD outside the United States and Canada, today announced that they have entered into an agreement under which Allergan will acquire the exclusive worldwide rights to Merck's investigational small molecule oral calcitonin gene-related peptide (CGRP) receptor antagonists, which are being developed for the treatment and prevention of migraine, subject to expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR).
A study that used a Utah genealogic database and a statewide cancer registry to examine the relationship between Parkinson disease (PD) and cancer suggests an increased risk of prostate cancer and melanoma in patients with PD and their relatives, according to a report published Online First by Archives of Neurology, a JAMA Network publication.
Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders, which is being conducted in collaboration with Pfizer. As previously reported, the companies recently selected a candidate compound to advance into further clinical studies. Dosing of this candidate compound has now been initiated in a Phase I study in healthy volunteers.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bela D Desai, MD P.o. Box 1935, Des Plaines, IL 60017-1935 Ph: (847) 803-1344 | Bela D Desai, MD 77 Rand Rd, Des Plaines, IL 60016-1005 Ph: (847) 803-1344 |
News Archive
Newly-created bioactive peptides promote wound healing through the growth of new blood vessels and epithelial tissue, such as skin. These wound-healing peptides, synthesized by researchers at the Tufts Center for Innovations in Wound Healing Research, increased angiogenesis in vitro by 200 percent.
A new treatment option for Canadians with schizophrenia, ABILIFY(TM) (aripiprazole), is now available in Canada. For those living with this lifelong disease who may be struggling with a treatment that doesn't work for them or with side effects that are difficult to tolerate, ABILIFY offers efficacy and good safety and tolerability with limited impact on weight, blood sugar and lipids - significant clinical benefits that may help patients stay on treatment longer.
Allergan plc and Merck, known as MSD outside the United States and Canada, today announced that they have entered into an agreement under which Allergan will acquire the exclusive worldwide rights to Merck's investigational small molecule oral calcitonin gene-related peptide (CGRP) receptor antagonists, which are being developed for the treatment and prevention of migraine, subject to expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR).
A study that used a Utah genealogic database and a statewide cancer registry to examine the relationship between Parkinson disease (PD) and cancer suggests an increased risk of prostate cancer and melanoma in patients with PD and their relatives, according to a report published Online First by Archives of Neurology, a JAMA Network publication.
Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders, which is being conducted in collaboration with Pfizer. As previously reported, the companies recently selected a candidate compound to advance into further clinical studies. Dosing of this candidate compound has now been initiated in a Phase I study in healthy volunteers.
› Verified 1 days ago
Steven Hendler, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 900 Rand Rd Ste 120, Des Plaines, IL 60016 Phone: 312-767-3244 | |
Dr. Zuie Wakade, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 900 Rand Rd Ste 120, Des Plaines, IL 60016 Phone: 312-767-3244 | |
Rajan H Patel, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 9301 Golf Rd, Suite 302, Des Plaines, IL 60016 Phone: 847-296-8151 Fax: 847-296-3915 | |
Gary K Artinian, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 77 Rand Rd, Des Plaines, IL 60016 Phone: 847-298-0310 Fax: 847-298-5939 | |
Dr. Mukund Venu, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 900 Rand Rd Ste 120, Des Plaines, IL 60016 Phone: 312-767-3244 | |
Peter Werner, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 150 N River Rd, Suite 210, Des Plaines, IL 60016 Phone: 847-759-4060 Fax: 847-759-4066 |